Histological and immunohistochemical observations of mucin-depleted foci (MDF) stained with Alcian blue, in rat colon carcinogenesis induced with 1,2-dimethylhydrazine dihydrochloride

Cancer Science

Volumn 95, Issue 10, 2004, Pages 792-797

  Yoshimi, Naoki ^a   Morioka, Takamitsu ^a   Kinjo, Tatsuya ^a   Inamine, Morihiko ^a   Kaneshiro, Tatsuya ^a   Shimizu, Takahiro ^a   Suzui, Masumi ^a   Yamada, Yasuhiro ^b   Mori, Hideki ^b  

^a UNIVERSITY OF THE RYUKYUS SCHOOL OF MEDICINE   (Japan)

^b GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1,2 DIMETHYLHYDRAZINE; ALCIAN BLUE; BETA CATENIN; BIOCHEMICAL MARKER; DRINKING WATER; FORMALDEHYDE; INDOMETACIN; MUCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CANCER TISSUE; CLINICAL OBSERVATION; COLON CARCINOGENESIS; COLON CARCINOMA; COMPUTER ANALYSIS; CONTROLLED STUDY; DYSPLASIA; HISTOPATHOLOGY; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; INTESTINE CRYPT; MALE; NONHUMAN; PRIORITY JOURNAL; RANDOMIZATION; RAT; RAT STRAIN; STATISTICAL SIGNIFICANCE; TISSUE FIXATION;

1,2-DIMETHYLHYDRAZINE; ALCIAN BLUE; ANIMALS; BETA CATENIN; CARCINOGENS; COLONIC NEOPLASMS; CYTOSKELETAL PROTEINS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; MALE; MUCINS; PRECANCEROUS CONDITIONS; RATS; RATS, INBRED F344; STAINING AND LABELING; TRANS-ACTIVATORS; TUMOR MARKERS, BIOLOGICAL;

EID: 9144249036     PISSN: 13479032     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2004.tb02183.x     Document Type: Article

References (30)

1. Bird RP. Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. Cancer Lett 1987; 37: 147-51.
2. Corpet DE, Tache S. Most effective colon cancer chemopreventive agents in rats: a systematic review of aberrant crypt foci and tumor data, ranked by potency. Nutr Cancer 2002; 43: 1-21.
3. Magnuson BA, Carr I, Bird RP. Ability of aberrant crypt foci characteristics to predict colonic tumor incidence in rats fed cholic acid. Cancer Res 1993; 53: 4499-504.
4. Zheng Y, Kramer PM, Lubet RA, Steele VE, Kelloff GJ, Pereira MA. Effect of retinoids on AOM-induced colon cancer in rats: modulation of cell proliferation, apoptosis and aberrant crypt foci. Carcinogenesis 1999; 20: 255-60.
5. Caderni G, Femia AP, Giannini A, Favuzza A, Luceri C, Salvadori M, Dolara P. Identification of mucin-depleted foci in the unsectioned colon of azoxymethane-treated rats: correlation with carcinogenesis. Cancer Res 2003; 63: 2388-92.
6. Yamada Y, Yoshimi N, Hirose Y, Kawabata K, Matsunaga K, Shimizu M, Hara A, Mori H. Frequent beta-catenin gene mutations and accumulations of the protein in the putative preneoplastic lesions lacking macroscopic aberrant crypt foci appearance, in rat colon carcinogenesis. Cancer Res 2000; 60: 3323-7.
7. Yamada Y, Yoshimi N, Hirose Y, Matsunaga K, Katayama M, Sakata K, Shimizu M, Kuno T, Mori H. Sequential analysis of morphological and biological properties of beta-catenin-accumulated crypts, provable premalignant lesions independent of aberrant crypt foci in rat colon carcinogenesis. Cancer Res 2001; 61: 1874-8.
8. Takahashi M, Fukuda K, Sugimura T, Wakabayashi K. Beta-catenin is frequently mutated and demonstrates altered cellular location in azoxymethane-induced rat colon tumors. Cancer Res 1998; 58: 42-6.
9. Suzui M, Ushijima T, Dashwood RH, Yoshimi N, Sugimura T, Mori H, Nagao M. Frequent mutations of the rat beta-catenin gene in colon cancers induced by methylazoxymethanol acetate plus 1-hydroxyanthraquinone. Mol Carcinog 1999; 24: 232-7.
10. Suzui M, Sugie S, Mori H, Okuno M, Tanaka T, Moriwaki H. Different mutation status of the beta-catenin gene in carcinogen-induced colon, brain, and oral tumors in rats. Mol Carcinog 2001; 32: 206-12.
11. Dashwood RH, Suzui M, Nakagama H, Sugimura T, Nagao M. High frequency of beta-catenin (ctnnb1) mutations in the colon tumors induced by two heterocyclic amines in the F344 rat. Cancer Res 1998; 58 1127-9.
12. Harada N, Tamai Y, Ishikawa T, Sauer B, Takaku K, Oshima M, Taketo MM. Intestinal polyposis in mice with a dominant stable mutation of the beta-catenin gene. EMBO J 1999; 18: 5931-42.
13. Femia AP, Dolara P, Caderni G. Mucin-depleted foci (MDF) in the colon of rats treated with azoxymethane (AOM) are useful biomarkers for colon carcinogenesis. Carcinogenesis 2004; 25: 277-81.
14. Morioka T, Suzui M, Nabandith V, Inamine M, Aniya Y, Nakayama T, Ichiba T, Mori H, Yoshimi N. The modifying effect of Peucedanum japonicum, a herb in the Ryukyu Islands, on azoxymethane-induced colon preneoplastic lesions in male F344 rats. Cancer Lett 2004; 205 133-41.
15. Kawabata K, Tanaka T, Murakami T, Okada T, Murai H, Yamamoto T, Hara A, Shimizu M, Yamada Y, Matsunaga K, Kuno T, Yoshimi N, Sugie S, Mori H. Dietary prevention of azoxymethane-induced colon carcinogenesis with rice-germ in F344 rats. Carcinogenesis 1999; 20: 2109-15.
16. Yoshimi N, Shimizu M, Matsunaga K, Yamada Y, Fujii K, Hara A, Mori, H. Chemopreventive effect of N-(2-cyclohexyloxy-4-nitrophenyl)methane sulfonamide (NS-398), a selective cyclooxygenase-2 inhibitor, in rat colon carcinogenesis induced by azoxymethane. Jpn J Cancer Res 1999; 90: 406-12.
17. Yamada Y, Yoshimi N, Hirose Y, Hara A, Shimizu M, Kuno T, Katayama M, Qiao Z, Mori H. Suppression of occurrence and advancement of beta-catenin-accumulated crypts, possible premalignant lesions of colon cancer, by selective cyclooxygenase-2 inhibitor, celecoxib. Jpn J Cancer Res 2001; 92: 617-23.
18. Takahashi M, Mutoh M, Kawamori T, Sugimura T, Wakabayashi K. Altered expression of β-catenin, inducible nitric oxide synthase and cyclooxygenase-2 in azothymethane-induced rat colon carcinogenesis. Carcinogenesis 2000; 21: 1319-27.
19. Ohchiai M, Ushigome M, Fujiwara K, Ubegai T, Kawamori T, Sugimura T, Nagao N, Nakagama H. Characterization of dysplastic aberrant crypt foci in the rat colon induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Am J Pathol 2003; 163: 1607-14.
20. Takahashi M, Wakabayashi K. Gene mutations and altered gene expression in azoxymethane-induced colon carcinogenesis in rodents. Cancer Sci 2004; 95: 475-80.
21. Hirose Y, Kano T, Yamada Y, Sakata K, Katayama M, Yoshida K, Qiao Z, Hata K, Yoshimi N, Mori H. Azoxymethane-induced beta-catenin-accumulated crypts in colonic mucosa of rodents as an intermediate biomarker for colon carcinogenesis. Carcinogenesis 2003; 24: 107-11.
22. Yamada Y, Mori H. Pre-cancerous lesions for colorectal cancers in rodents: a new concept. Carcinogenesis 2003; 24: 1015-9.
23. Gendler SJ, Spicer AP. Epithelial mucin genes. Annu Rev Physiol 1995; 57: 607-34.
24. Kim YS, Gum J Jr, Brockhausen I. Mucin glycoproteins in neoplasia. Glycoconj J 1996; 13: 693-707.
25. Zusman I, Zimber A, Nyska A. Role of morphological methods in the analysis of chemically induced colon cancer in rats. Acta Anat (Basel) 1991; 142: 351-6.
26. Dawson PA, Patel J, Filipe MI. Variations in sialomucins in the mucosa of the large intestine in malignancy: a quantimet and statistical analysis. Histochem J 1978; 10: 559-72.
27. Filipe MI. Value of histochemical reactions for mucosubstances in the diagnosis of certain pathological conditions of the colon and rectum. Gut 1969; 10: 577-86.
28. Matsushita Y, Yamamoto N, Shirahama H, Tanaka S, Yonezawa S, Yamori T, Irimura T, Sato E. Expression of sulfomucins in normal mucosae, colorectal adenocarcinomas, and metastases. Jpn J Cancer Res 1995; 86: 1060-7.
29. Sandforth F, Heimpel S, Balzer T, Gutschmidt S, Riecken EO. Characterization of stereomicroscopically identified preneoplastic lesions during dimethylhydrazine-induced colonic carcinogenesis. Eur J Clin Invest 1988; 18: 655-62.
30. Filipe MI. Mucous secretion in rat colonic mucosa during carcinogenesis induced by dimethylhydrazine. A morphological and histochemical study. Br J Cancer 1975; 32: 60-77.